Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Outcome Analysis for APAC High Risk Localized Prostate Cancer Patients Treated With Radical Prostatectomy and Perioperative Hormonal Therapy

NCT05303558 is registered in ClinicalTrials.gov with Johnson & Johnson International (Singapore) Pte. Ltd. as lead sponsor.

NCT NCT05303558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05303558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Outcome Analysis for APAC High Risk Localized Prostate Cancer Patients Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Lead sponsor
Johnson & Johnson International (Singapore) Pte. Ltd.
Phase
Observational
Overall status
Completed
Start date
August 24, 2022
Completion date
June 7, 2023
Enrollment
221 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

high risk localized prostate cancer